JD
Jayson Donald Alexander Dallas
Director

Jayson Donald Alexander Dallas insider trades: Arena Pharmaceuticals (ARNA) stock buys and sales

Director, Arena Pharmaceuticals Last trade Jun 15, 2021 36 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
7
Open-market trades
since 2018
4
Companies
last trade 2021

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Jayson reports to the SEC

Open-market buys and sales

7 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 15, 2021ARNA↓ Sell$81K
Jan 19, 2021ARNA↓ Sell$107K
Dec 11, 2020ARNA↑ Buy$347
Dec 8, 2020ARNA↑ Buy$331
Mar 10, 2020AIMT↑ Buy$50K
Jun 14, 2019ARNA↓ Sell$85K
Nov 19, 2018AIMT↑ Buy$101K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Jayson Donald Alexander Dallas's insider trades

Jayson Donald Alexander Dallas is a director at Arena Pharmaceuticals (ARNA). Since Nov 19, 2018, Jayson has reported 4 open-market purchases worth $151K and 3 sales worth $273K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (22 filings), shares withheld for taxes (8 filings), shares returned to the company (2 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ARNA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.